Delivery Order SPE2DB24D2216-SPE2DB25FGPWE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,270.30 to AmerisourceBergen Drug Corp for Comirnaty 2024-25 vaccine (12 years and up, 0.3mL syringes) with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued on August 18, 2025, carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.55 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 20, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,175.75 to AmerisourceBergen Drug Corp for Comirnaty 2024-25 vaccine (12 years and up, 0.3mL syringes) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action under a larger vehicle, this delivery order falls within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,540.60 to AmerisourceBergen Drug Corp for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3 mL syringes. The award was made on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizing firm fixed price delivery order contract terms. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility and was awarded competitively without set-aside designation. This...
- The Defense Logistics Agency (DLA) awarded a $12,703.00 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine doses (0.3mL syringes for ages 12 and up). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performs the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,270.30 on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, identified as COMIRNATY 2024-25 (12 years and up) at 0.3 milliliters, represents a single-dose vaccine supply for military healthcare operations. The contract was competitively awarded with no set-aside provisions and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3ml syringes, with a contract ceiling value of $2,220.84 and an ultimate completion date of March 13, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order is a child...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $157,765 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year formulation, 0.3ml syringes) on September 23, 2025, with completion by September 24, 2025. This non-set-aside competitive award was placed of performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under the company's broader Indefinite Delivery Contract...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract valued at $22,175.70 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of COMIRNATY (COVID-19 vaccine) for individuals aged 12 and above, with a completion date of February 16, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will supply the vaccines from its corporate...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $73,350 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The award is for the supply of COMIRNATY 2024-25 (12 years and up) syringes, 0.3 mL, with an ultimate completion date of September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, under which...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPWEDelivery Order
The Defense Logistics Agency awarded a $25,242.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12 years and up, 0.3ml syringes) with an ultimate completion date of October 15, 2025. This non-set-aside award was issued on September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents one of many pharmaceutical supply transactions the company fulfills through its federal procurement relationships. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's capability to compete for and fulfill such awards demonstrates its established role as a critical pharmaceutical distributor for Department of Defense and federal healthcare system needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.2k | 9/23/25 |